[ET Net News Agency, 3 December 2025] Citi lowered the target price for Giant Biogene
(02367) to HKD44.6 from HKD55.4 and maintained the "buy" rating.
The research house said it expects 2026E to resume growth in the teens percentage given
the continuous growth of self-livestreaming and mid-tier KOL livestreaming, along with a
few major new products. (rc)